• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to 4-(2,5-Difluorophenyl)-2-methylphenol (CAS No. 1262001-57-9)

4-(2,5-Difluorophenyl)-2-methylphenol, identified by the Chemical Abstracts Service Number (CAS No.) 1262001-57-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of arylphenols, characterized by a phenolic hydroxyl group (-OH) attached to an aromatic ring. The presence of fluorine atoms at the 2 and 5 positions on the phenyl ring introduces unique electronic and steric properties, making this molecule a promising candidate for various applications in medicinal chemistry and material science.

The structural motif of 4-(2,5-Difluorophenyl)-2-methylphenol combines the aromatic stability of a benzene ring with the electron-withdrawing effects of fluorine atoms, which can modulate the reactivity and binding affinity of the molecule. The methyl group at the 2-position further influences the electronic distribution and potential interactions with biological targets. Such structural features make it an intriguing subject for synthetic chemists and biologists exploring novel pharmacophores.

In recent years, there has been growing interest in arylphenol derivatives due to their diverse biological activities. Studies have demonstrated that modifications in the phenolic moiety can lead to significant changes in pharmacological properties, including antioxidant, anti-inflammatory, and antimicrobial effects. The fluorinated derivatives, in particular, have shown enhanced metabolic stability and improved bioavailability compared to their non-fluorinated counterparts.

4-(2,5-Difluorophenyl)-2-methylphenol has been investigated for its potential role in drug discovery. Its unique structure allows for selective interactions with biological targets, which is a critical factor in developing effective therapeutics. Researchers have explored its derivatives as intermediates in synthesizing more complex molecules with tailored pharmacological profiles. The compound's ability to act as a scaffold for further functionalization makes it a valuable asset in medicinal chemistry libraries.

The synthesis of 4-(2,5-Difluorophenyl)-2-methylphenol involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as cross-coupling reactions and palladium-catalyzed transformations, have been employed to construct the desired fluorinated arylphenol structure efficiently. The use of fluorinating agents and protecting groups plays a crucial role in achieving the correct regioisomer during synthesis.

From a chemical biology perspective, 4-(2,5-Difluorophenyl)-2-methylphenol has been studied for its interaction with enzymes and receptors. Preliminary computational studies suggest that the fluorine atoms can enhance binding affinity by participating in halogen bonding interactions with biological targets. This mechanism is particularly relevant in designing small-molecule inhibitors for therapeutic applications. Additionally, the compound's phenolic hydroxyl group provides a site for hydrogen bonding, further contributing to its binding specificity.

The pharmacokinetic properties of 4-(2,5-Difluorophenyl)-2-methylphenol have also been evaluated through in vitro and in vivo models. These studies indicate that the compound exhibits moderate solubility in aqueous environments due to the presence of polar functional groups, which is favorable for drug formulation. Furthermore, preliminary toxicology assessments suggest that it is well-tolerated at moderate doses, although further studies are needed to fully characterize its safety profile.

In conclusion, 4-(2,5-Difluorophenyl)-2-methylphenol (CAS No. 1262001-57-9) represents a promising compound with potential applications in pharmaceutical research and development. Its unique structural features and demonstrated biological activity make it an attractive candidate for further exploration. As research continues to uncover new therapeutic targets and synthetic strategies, this molecule is likely to play a significant role in advancing drug discovery efforts.

• 1261916-03-3(2-(2,3-difluorophenyl)phenol)
• 1261959-10-7(2-(2-Fluoro-5-methylphenyl)phenol)
• 439-80-5(2''-fluorobiphenyl-2-ol)
• 1261951-38-5(2-(3-fluoro-4-methylphenyl)phenol)
• 1261995-53-2(2-(2,5-Difluorophenyl)phenol)
• 1255636-13-5(4-(2-Fluorophenyl)-2-methylphenol)
• 1261888-30-5(4-(2-Fluoro-4-methylphenyl)-2-methylphenol)
• 1261889-98-8(5-(2,4-Difluorophenyl)-2-methylphenol)
• 1261917-32-1(2-Methyl-4-(2,4,6-trifluorophenyl)phenol)
• 1261983-83-8(2-(2-fluoro-4-methylphenyl)phenol)